Biogen projects 2026 revenue drop despite Q4 beat
Source: SeekingAlpha
2026-02-06 07:02:19 ET
More on Biogen
- Biogen: Why I Anticipate A Difficult 2026 For 'End Of An Era' Pharma
- 44th Annual J.P. Morgan Healthcare Conference
- Biogen Inc. (BIIB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Biogen beats top-line and bottom-line estimates; initiates FY26 outlook
- Biogen Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Biogen projects 2026 revenue drop despite Q4 beat
BioArctic
NASDAQ: BRCTF
BRCTF Trading
0.0% G/L:
$33.02 Last:
108 Volume:
$33.02 Open:
